M

Mabwell Shanghai Bioscience Co Ltd
SSE:688062

Watchlist Manager
Mabwell Shanghai Bioscience Co Ltd
SSE:688062
Watchlist
Price: 22.92 CNY -2.51%
Market Cap: 9.2B CNY
Have any thoughts about
Mabwell Shanghai Bioscience Co Ltd?
Write Note

Operating Margin
Mabwell Shanghai Bioscience Co Ltd

-540.3%
Current
-4 214%
Average
-7.8%
Industry

Operating Margin represents how efficiently a company is able to generate profit through its core operations.

Higher ratios are generally better, illustrating the company is efficient in its operations and is good at turning sales into profits.

Operating Margin
-540.3%
=
Operating Profit
-1B
/
Revenue
191.4m

Operating Margin Across Competitors

Country Company Market Cap Operating
Margin
CN
Mabwell Shanghai Bioscience Co Ltd
SSE:688062
9.2B CNY
-540%
FR
Pharnext SCA
OTC:PNEXF
6T USD
-17 527%
US
Abbvie Inc
NYSE:ABBV
320.1B USD
28%
US
Amgen Inc
NASDAQ:AMGN
147.4B USD
19%
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
119.4B USD
40%
US
Gilead Sciences Inc
NASDAQ:GILD
113.8B USD
38%
US
Epizyme Inc
F:EPE
94.1B EUR
-370%
AU
CSL Ltd
ASX:CSL
135.4B AUD
26%
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
82.6B USD
30%
US
Seagen Inc
F:SGT
39.3B EUR
-33%
NL
argenx SE
XBRU:ARGX
34.3B EUR
-22%
Country CN
Market Cap 9.2B CNY
Operating Margin
-540%
Country FR
Market Cap 6T USD
Operating Margin
-17 527%
Country US
Market Cap 320.1B USD
Operating Margin
28%
Country US
Market Cap 147.4B USD
Operating Margin
19%
Country US
Market Cap 119.4B USD
Operating Margin
40%
Country US
Market Cap 113.8B USD
Operating Margin
38%
Country US
Market Cap 94.1B EUR
Operating Margin
-370%
Country AU
Market Cap 135.4B AUD
Operating Margin
26%
Country US
Market Cap 82.6B USD
Operating Margin
30%
Country US
Market Cap 39.3B EUR
Operating Margin
-33%
Country NL
Market Cap 34.3B EUR
Operating Margin
-22%
No Stocks Found

Mabwell Shanghai Bioscience Co Ltd
Glance View

Market Cap
9.2B CNY
Industry
Biotechnology

Mabwell (Shanghai) Bioscience Co., Ltd. engages in the research and development, production and sales of therapeutic biological products. The company is headquartered in Shanghai, Shanghai and currently employs 1,052 full-time employees. The company went IPO on 2022-01-18. The firm's main businesses include the establishment of new varieties of drugs and the discovery of some early projects, the organization and development of preclinical research and pharmacological effects, and the development of drugs for preclinical research. The firm is also engaged in the organization, management and development of clinical trials of research species. The firm's research on drugs covers autoimmune, tumor, metabolism, ophthalmology, infection and other disease fields. The firm conducts business in domestic and foreign markets.

Intrinsic Value
27.94 CNY
Undervaluation 18%
Intrinsic Value
Price
M

See Also

Discover More
What is Operating Margin?

Operating Margin represents how efficiently a company is able to generate profit through its core operations.

Higher ratios are generally better, illustrating the company is efficient in its operations and is good at turning sales into profits.

Operating Margin
-540.3%
=
Operating Profit
-1B
/
Revenue
191.4m
What is the Operating Margin of Mabwell Shanghai Bioscience Co Ltd?

Based on Mabwell Shanghai Bioscience Co Ltd's most recent financial statements, the company has Operating Margin of -540.3%.